Diabetes & Metabolic Education

Where doctors read, learn, and stay sharp.

Docuniv is a purpose-built reading platform for doctors treating diabetes and metabolic disorders only — bringing together peer-reviewed articles, rich case studies, conference highlights, evidence-based guidelines, clinical algorithms, and a live AI tutor, all in one mobile-first space designed for the pace of real clinical life.

Doctor reviewing medical content at a desk
Doctor reading and taking notes at laptop
Two doctors reviewing case on a tablet

What is DocUniv?

A doctor explains in 30 seconds what DocUniv is and why doctors should be on it. Tap play, with sound on.

Featured Articles

All articles →
Doctors reviewing medical articles together
Peer-reviewed. Evidence-based. Updated daily.
Article Early Identification and Management of Type 2 Diabetes in Primary Care

Type 2 diabetes is silent for years. Opportunistic screening, prompt confirmation and early intensive management in primary care reduce long-term c...

✓ Content reviewer: Baishali
Article Semaglutide in Type 2 Diabetes: Lessons from the SUSTAIN and PIONEER Programmes

SUSTAIN (injectable) and PIONEER (oral) programmes established semaglutide as a potent glucose- and weight-lowering agent with cardiovascular safet...

✓ Content reviewer: Baishali
Article Semaglutide versus Tirzepatide for Obesity and Type 2 Diabetes: Interpreting SURMOUNT-5

SURMOUNT-5, the first randomised head-to-head trial in obesity, showed greater weight loss with tirzepatide than semaglutide over 72 weeks. Earlier...

✓ Content reviewer: Baishali
Article Kidney Protection with GLP-1 Receptor Agonists: FLOW Trial Evidence in Type 2 Diabetes with CKD

FLOW showed that once-weekly semaglutide 1.0 mg reduced major kidney events by 24% in people with type 2 diabetes and chronic kidney disease (CKD),...

✓ Content reviewer: Suja
Article GLP-1 Receptor Agonist Safety: Retinopathy, Psychiatric Signals and Perioperative Guidance

GLP-1 receptor agonists are generally well tolerated, but concerns regarding diabetic retinopathy, optic neuropathy, psychiatric effects and aspira...

✓ Content reviewer: Suja
Case Study Identifying MASLD and Assessing Fibrosis Risk in a Patient with Type 2 Diabetes

Metabolic dysfunction-associated steatotic liver disease (MASLD) is frequently encountered in individuals with type 2 diabetes mellitus (T2DM) and ...

✓ Content reviewer: Suja

Sections

Tools

Clinical Tutor

Live · No sign-in needed

Ask a clinical question right now.

Type a question about medicines, diet, symptoms, cases, algorithms, guidelines, or conference updates.

Your AI tutor is ready without an account. Type a question — drug interactions, differential diagnoses, dosing, guidelines — and continue into full guided learning modules when you're ready to go deeper.

Enter to ask · Shift+Enter for new line

Today

Doctor studying and taking notes
Your daily reading, curated. Start where it matters most.
Live tutor
Ask a clinical question right now.

Type a question about medicines, diet, symptoms, cases, algorithms, guidelines, or conference updates.

I am ready. Ask about medicines, diets, diabetes, case reasoning, conference highlights, guidelines, or algorithms.
Enter to ask · Shift+Enter for new line